HANDOK Inc. (KRX:002390)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,000.00
+80.00 (1.16%)
Last updated: Jun 24, 2026, 2:14 PM KST
Market Cap89.90B -43.1%
Revenue (ttm)550.69B +10.5%
Net Income-3.02B
EPS-229.65
Shares Out 12.99M
PE Ration/a
Forward PEn/a
Dividend200.00 (2.69%)
Ex-Dividend DateFeb 26, 2026
Volume21,715
Open6,800.00
Previous Close6,920.00
Day's Range6,800.00 - 7,040.00
52-Week Range6,900.00 - 13,460.00
Beta0.24
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About HANDOK

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products. In addition, the company engages in real estate leasing. The co... [Read more]

Sector Healthcare
Founded 1954
Employees 940
Stock Exchange Korea Stock Exchange
Ticker Symbol 002390
Full Company Profile

Financial Performance

In 2025, HANDOK's revenue was 535.14 billion, an increase of 5.48% compared to the previous year's 507.36 billion. Losses were -2.15 billion, -95.90% less than in 2024.

Financial Statements